Circulating causal protein networks linked to future risk of myocardial infarction

Sean Bankier1,2, Valborg Gudmundsdottir2,3, Thorarinn Jonmundsson3

  • 1Computational Biology Unit, Department of Informatics, University of Bergen, P.O. Box 7803, 5020 Bergen, Norway.

Insights

This study reveals causal protein networks linked to cardiovascular disease. Understanding these systemic interactions offers new insights into heart health and disease prevention.

Area of Science:

  • Proteomics
  • Systems Biology
  • Cardiovascular Disease Research

Background:

  • Blood protein variations are linked to complex diseases like atherosclerotic cardiovascular disease (ACVD).
  • Understanding the interplay of local and systemic factors is crucial for ACVD etiology.
  • A comprehensive, systems-level approach is needed to understand ACVD development.

Purpose of the Study:

  • To develop a causal network inference framework for serum proteins.
  • To analyze one of the largest serum proteomics datasets (AGES study).
  • To identify causal relationships between proteins and their role in ACVD.

Main Methods:

  • Utilized the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES) dataset (5,376 older adults).
  • Analyzed 7,523 serum proteins using a causal network inference framework.
  • Employed cis-acting protein quantitative trait loci (pQTLs) as instrumental variables to infer causal protein-protein interactions.

Main Results:

  • Identified 185 significant causal protein subnetworks (FDR = 1%, n ≥ 10 members).
  • These subnetworks interact with 5,611 target proteins, providing insights into systemic homeostasis.
  • Several subnetworks showed significant associations with future myocardial infarction, heart failure, and cardiometabolic traits.

Conclusions:

  • Causal protein networks play a significant role in the etiology of atherosclerotic cardiovascular disease.
  • The identified subnetworks offer biological insights into systemic homeostasis and disease pathways.
  • This framework advances our understanding of ACVD pathogenesis and potential therapeutic targets.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
82
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K